跳至主要内容
临床试验/CTRI/2025/05/087330
CTRI/2025/05/087330尚未招募2/3 期

PHARMACEUTICO ANALYTICAL and EXPLORATORY THERAPEUTIC POTENTIAL OF GANDHAKA KALPA and AKSHITARAPANA WITH GOGHRITA IN SIMPLE MYOPIA

Post Graduate Institute of Ayurved, Jodhpur, Rajasthan1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年1月3日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Change in subjective parameters

研究概览

简要总结

Myopia, a widespread refractive error in todays world and  is becoming increasingly prevalent due to increased screen time and use of smartphones and gadgets for longer durations. The incidence of myopia in children is on the rise and worsens as they get older. The frequency of myopia in India is on the incline, particularly in urban areas. Among urban schoolchildren aged 5-15 years, the prevalence escalated from 4.4% in 1999 to 21.1% in 2019. Forecasts indicate that by 2030, it might reach approximately 31.89%, and by 2050, nearly 48.14%2.

Gandhak Kalpa contains medicinal plants along with Shuddha Gandhak. Triphala and Bhringraj have antioxidant and anti inflammatory properties and are potent medicines for improving eyesight.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Open Label

入排标准

年龄范围
10.00 Year(s) 至 25.00 Year(s)(—)
性别
All

入选标准

  • Myopia upto -6D will be included in the study.

排除标准

  • a)Patient age below 10 and above 25 years of age.
  • b)Patients having Pathological myopia condition.
  • c)Patient with recent eye surgery or having any trauma.

结局指标

主要结局

Change in subjective parameters

时间窗: 90days

次要结局

  • Improvement in quality of life of patient(3 months)

研究者

发起方
Post Graduate Institute of Ayurved, Jodhpur, Rajasthan
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验

Ayurvedic Remedy Gandhak Kalpa for Myopia Treatment | 临床试验